Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/18/2010US20100292088 Methods and compositions for detecting genetic markers associated with primary ciliary dyskinesia
11/18/2010US20100292086 Method of screening for metabolite transport modifiers
11/18/2010US20100292085 Methods and compositions for characterization of HSD1 inhibitors
11/18/2010US20100291712 Manipulation of magnetic microparticles in a high pressure liquid system and extraction process
11/18/2010US20100291711 Integrated sensor microsystem and method for detecting biomolecules in liquid
11/18/2010US20100291710 Biosensor system for external actuation of magnetic particles in a biosensor cartridge
11/18/2010US20100291709 Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
11/18/2010US20100291708 Methods to diagnose a required regulation of trophoblast invasion
11/18/2010US20100291707 Multiplexed Scanometric Assay for Target Molecules
11/18/2010US20100291706 Dye conjugates and methods of use
11/18/2010US20100291705 Antigen exposing micelle and unordered aggregate
11/18/2010US20100291702 Functionalized Fluorescent Nanocrystal Compositions and Methods for Their Preparation
11/18/2010US20100291699 Compositions and methods for simultaneous detection of volatile sulfur compounds and polyamines
11/18/2010US20100291698 Detection of nitro- and nitrate-containing compounds
11/18/2010US20100291697 Coated Colloidal Materials
11/18/2010US20100291696 Process For Detecting Nucleic Acids
11/18/2010US20100291695 Detection of nucleic acid sequence modification
11/18/2010US20100291694 Crystal Structure of CRIg and C3B:CRIg Complex
11/18/2010US20100291693 Oral fluid assays for the detection of heavy metal exposure
11/18/2010US20100291692 Method for analyzing metal specimen
11/18/2010US20100291691 Method of measuring glycated hemoglobin concentration and concentration measuring apparatus
11/18/2010US20100291690 Methods for detecting or monitoring cancer using lpc as a marker
11/18/2010US20100291689 Lanthanide Complexes as Fluorescent Indicators for Neutral Sugars and Cancer Diagnosis
11/18/2010US20100291687 An assay for screening/ranking antioxidants based on their effects on membrane sterol lateral organization
11/18/2010US20100291686 Automated protein analyzer
11/18/2010US20100291681 Methods and compositions for selecting siRNA of improved functionality
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291665 Biocompatible three dimensional matrix for the immobilization of biological substances
11/18/2010US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/18/2010US20100291611 Assays
11/18/2010US20100291602 Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
11/18/2010US20100291601 Carbohydrate binding module and use thereof
11/18/2010US20100291600 Immunoassay
11/18/2010US20100291599 Large area scanning apparatus for analyte quantification by surface enhanced raman spectroscopy and method of use
11/18/2010US20100291598 Prion elisa
11/18/2010US20100291597 Secretogranin and vgf peptide biomarkers and uses thereof
11/18/2010US20100291596 Screening method for agents suitable for therapy of alzheimer's disease
11/18/2010US20100291595 Blood monocyte cd163 expression as a biomarker in hiv-1 infection and neuroaids
11/18/2010US20100291594 ErbB Surface Receptor Complexes as Biomarkers
11/18/2010US20100291593 Method of identifying diagnostic reagents
11/18/2010US20100291592 Novel marker for sensitivity against sulfonamide compound
11/18/2010US20100291591 Novel plating media
11/18/2010US20100291590 Methods for the diagnosis and the prognosis of a brain tumor
11/18/2010US20100291589 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/18/2010US20100291588 Systems and methods including self-contained cartridges with detection systems and fluid delivery systems
11/18/2010US20100291587 Biomarker for diagnosing heart disease and the use thereof
11/18/2010US20100291586 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
11/18/2010US20100291584 Microfluidic imaging cytometry
11/18/2010US20100291581 Aldehyde Dehydrogenase 1 (ALDH1) as a Cancer Stem Cell Marker
11/18/2010US20100291580 Biomarkers for trichogenicity
11/18/2010US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/2010US20100291577 Toll-Like Receptor 9 Modulators
11/18/2010US20100291575 Detection of Changes in Cell Populations and Mixed Cell Populations
11/18/2010US20100291573 Methods of Predicting Cancer Risk Using Gene Expression in Premalignant Tissue
11/18/2010US20100291570 Materials and methods for detection of nucleic acids
11/18/2010US20100291566 Systems and methods for diagnosis and monitoring of bacteria-related conditions
11/18/2010US20100291565 Detection of Methylation in Nucleic Acid Sequences
11/18/2010US20100291563 Assessing tissue rejection
11/18/2010US20100291560 Methods and compositions for diagnosis and treatment of dyskeratosis congenita and related disorders
11/18/2010US20100291557 Binary probe and clamp composition and methods for target hybridization detection
11/18/2010US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses
11/18/2010US20100291550 Methods and compositions for modulating hair growth
11/18/2010US20100291547 Fluorogenic hydrazine-substituted compounds
11/18/2010US20100291546 Method for detection of hepatitis b virus
11/18/2010US20100291543 Homogeneous in vitro fec assays and components
11/18/2010US20100291542 Rapid immunochromatographic detection by amplification of the colloidal gold signal
11/18/2010US20100291224 Nanostructures, methods of preparing and uses thereof
11/18/2010US20100291189 Method for producing a membrane protein
11/18/2010US20100291188 Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same
11/18/2010US20100291142 Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof
11/18/2010US20100291133 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
11/18/2010US20100291131 Clostridial toxin netb
11/18/2010US20100291126 Protein showing enhanced expression in cancer cells
11/18/2010US20100291124 Extracellular serine protease
11/18/2010US20100291121 Tumour-Specific Animal Proteins
11/18/2010US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
11/18/2010US20100291114 Crystal structures and methods using same
11/18/2010US20100291113 Treatment of Proliferative Disorders Using Antibodies to PSMA
11/18/2010US20100291108 Antibodies to irem-1
11/18/2010US20100291105 Agent for the treatment of malignant diseases
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/18/2010US20100291100 Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291097 Monoclonal antibody
11/18/2010US20100291094 Nucleic acid encoding 238p1b2 useful in detecting cancer
11/18/2010US20100291092 Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases
11/18/2010US20100291091 Cancer associated gene ly6k
11/18/2010US20100291090 Prion Protein as a Receptor for Amyloid-Beta Oligomers
11/18/2010US20100291078 Proteinaceous binding molecules comprising purification tags or inert variable domains
11/18/2010US20100291074 Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease
11/18/2010US20100291072 Antibody variants with faster antigen association rates
11/18/2010US20100291071 Antibody Specific Binding to A-Beta Oligomer and the Use
11/18/2010US20100291068 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
11/18/2010US20100291066 Donor specific antibody libraries
11/18/2010US20100291032 Compositions and methods for the identification of inhibitors of retroviral infection
11/18/2010US20100291001 Metalloproteinase-binding proteins
11/18/2010US20100290996 Methods and compositions based on culturing microorganisms in low sedimental fluid shear conditions
11/18/2010US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 3937